Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches

NCT05306899 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Chronic Daily Headache

Interventions

DRUG: Ketamine
OTHER: 0.9% Saline

Sponsor

University Health Network, Toronto

Collaborators

[object Object]
[object Object]